- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
The Importance of Being Grade 3: A Plea for a Three-tier Hybrid Classification System for Grade in Primary Non-muscle-invasive Bladder Cancer.
September 6, 2024
IBCG Masterclass in Non-Muscle Invasive Bladder Cancer at the 2024 Société Internationale d'Urologie (SIU)
September 5, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.
September 5, 2024
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker.
September 5, 2024
Efficacy and Safety of Obturator Nerve Block in Transurethral Resection of Bladder Tumors: A Comprehensive Review.
September 3, 2024
A single-center retrospective comparison of pT1 substaging methods in bladder cancer.
September 3, 2024
Bladder sparing options for muscle-invasive bladder cancer.
September 3, 2024
Comprehensive behavioural assessment of TERT in bladder cancer.
September 2, 2024
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study.
September 2, 2024
Reducing financial toxicity in bladder cancer care.
September 2, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).
September 2, 2024
Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer.
August 30, 2024